Latin America Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Hb1Ac Testing, Coagulation, Fertility, Cardiac Markers, Infectious Diseases, Primary Acre Systems, Hematology) By End-Use (Clinics, Hospital, Home), And Segment Forecasts To 2024

Table of Content

Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.1.1 Increased awareness pertaining to medical status among the people
4.1.1.2 Penetration of key market entities in Latin America
4.1.1.3 Growing demand for home healthcare and the introduction of advance technology-enabled products
4.1.1.4 Growing geriatric population base
4.1.1.5 Growing prevalence of target diseases
4.1.2 Market Restraint Analysis
4.1.2.1 High procedure costs
4.1.2.2 High cost for product accession
4.2 Penetration & growth prospect mapping
4.3 Point of care diagnostics - SWOT Analysis, By Factor (political & legal, economic and technological)
4.4 Industry Analysis - Porter’s
4.5 Product positioning Analysis
Chapter 5 Market Categorization 1: Product Estimates & Trend Analysis
5.1 Latin America point of care diagnostics market: Product movement analysis
5.2 Glucose testing
5.2.1 Glucose testing market, 2013 - 2024 (USD Million)
5.3 Hb1Ac Testing
5.3.1 Hb1Ac testing market, 2013 - 2024 (USD Million)
5.4 Coagulation testing
5.4.1 Coagulationtesting market, 2013 - 2024 (USD Million)
5.5 Fertility testing
5.5.1 Fertility testing market, 2013 - 2024 (USD Million)
5.6 Cardiac markers
5.6.1 Cardiac markers market, 2013 - 2024 (USD Million)
5.7 Infectious disease testing
5.7.1 Infectious disease testing market, 2013 - 2024 (USD Million)
5.7.2 HIV POC
5.7.2.1 HIV POC market, 2013 - 2024 (USD Million)
5.7.3 Clostridium difficile POC
5.7.3.1 Clostridium difficile POC market, 2013 - 2024 (USD Million)
5.7.4 HBV POC
5.7.4.1 HBV POC market, 2013 - 2024 (USD Million)
5.7.5 Pneumonia or Streptococcus associated infections
5.7.5.1 Pneumonia or Streptococcus associated infections market, 2013 - 2024 (USD Million)
5.7.6 Respiratory syncytial virus (RSV) POC
5.7.6.1 Respiratory syncytial virus (RSV) POC market, 2013 - 2024 (USD Million)
5.7.7 HPV POC
5.7.7.1 HPV POC market, 2013 - 2024 (USD Million)
5.7.8 Influenza/Flu POC
5.7.8.1 Influenza/Flu POC market, 2013 - 2024 (USD Million)
5.7.9 HCV POC
5.7.9.1 HCV POC market, 2013 - 2024 (USD Million)
5.7.10 MRSA POC
5.7.10.1 MRSA POC market, 2013 - 2024 (USD Million)
5.7.11 TB and drug-resistant TB POC
5.7.11.1 TB and drug-resistant TB POC market, 2013 - 2024 (USD Million)
5.7.12 HSV POC
5.7.12.1 HSV POC market, 2013 - 2024 (USD Million)
5.7.13 Other Infectious Diseases
5.7.13.1 Other Infectious Diseases market, 2013 - 2024 (USD Million)
5.8 Primary care systems
5.8.1 Primary care systems market, 2013 - 2024 (USD Million)
5.9 Hematology testing
5.9.1 Hematology testing market, 2013 - 2024 (USD Million)
5.10 Decentralized clinical chemistry
5.10.1 Decentralized clinical chemistry market, 2013 - 2024 (USD Million)
5.11 Blood gas/electrolytes testing
5.11.1 Blood gas/electrolytes testing market, 2013 - 2024 (USD Million)
5.12 Ambulatory chemistry
5.12.1 Ambulatory chemistry market, 2013 - 2024 (USD Million)
5.13 Urinanalysis
5.13.1 Urinanalysis market, 2013 - 2024 (USD Million)
5.14 Drug abuse testing
5.14.1 Drug abuse testing market, 2013 - 2024 (USD Million)
Chapter 6 Market Categorization 2: End-use Estimates & Trend Analysis
6.1 Latin America point of care diagnostics market:end-use movement analysis
6.2 Clinics
6.2.1 Clinics market, 2013 - 2024 (USD Million)
6.3 Hospitals
6.3.1 Hospitals market, 2013 - 2024 (USD Million)
6.4 Home
6.4.1 Home market, 2013 - 2024 (USD Million)
6.5 Assiated living healthcare facilities
6.5.1 Assiated living healthcare facilities market, 2013 - 2024 (USD Million)
6.6 Laboratories
6.6.1 Laboratories market, 2013 - 2024 (USD Million)
6.7 Others
6.7.1 Other end-use market, 2013 - 2024 (USD Million)
Chapter 7 Market Categorization 3: Regional Estimates & Trend Analysis, by Product, & End-use
7.1 Latin America point of care diagnostics market share by region, 2015 & 2024
7.2 Brazil
7.2.1 Brazil point of care diagnostics market, 2013 - 2024 (USD Million)
7.3 Mexico
7.3.1 Mexico point of care diagnostics market, 2013 - 2024 (USD Million)
7.4 Chile
7.4.1 Chile point of care diagnostics market, 2013 - 2024 (USD Million)
7.5 Argentina
7.5.1 Argentina point of care diagnostics market, 2013 - 2024 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy framework
8.2 Market participation categorization
8.3 Company Profiles
8.3.1 Abbott Laboratories
8.3.1.1 Company Overview
8.3.1.2 Financial Performance
8.3.1.3 Product Benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 Alere Inc (Abbott)
8.3.2.1 Company Overview
8.3.2.2 Financial Performance
8.3.2.3 Product Benchmarking
8.3.2.4 Strategic Initiatives
8.3.3 Roche Diagnostics
8.3.3.1 Company Overview
8.3.3.2 Financial Performance
8.3.3.3 Product Benchmarking
8.3.3.4 Strategic Initiatives
8.3.4 Bio-rad Laboratories
8.3.4.1 Company Overview
8.3.4.2 Financial Performance
8.3.4.3 Product Benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 Danaher Corporation
8.3.5.1 Company Overview
8.3.5.2 Financial Performance
8.3.5.3 Product Benchmarking
8.3.5.4 Strategic Initiatives
8.3.6 bioMerieux
8.3.6.1 Company Overview
8.3.6.2 Financial Performance
8.3.6.3 Product Benchmarking
8.3.6.4 Strategic Initiatives
8.3.7 Agilent Technologies, Inc.
8.3.7.1 Company Overview
8.3.7.2 Financial Performance
8.3.7.3 Product Benchmarking
8.3.7.4 Strategic Initiatives
8.3.8 OraSure Technologies Inc
8.3.8.1 Company Overview
8.3.8.2 Financial Performance
8.3.8.3 Product Benchmarking
8.3.8.4 Strategic Initiatives
8.3.9 Siemens Healthineers
8.3.9.1 Company Overview
8.3.9.2 Financial Performance
8.3.9.3 Product Benchmarking
8.3.9.4 Strategic Initiatives
8.3.10 Abaxis Inc.
8.3.10.1 Company Overview
8.3.10.2 Financial Performance
8.3.10.3 Product Benchmarking
8.3.10.4 Strategic Initiatives

List of Tables

TABLE 1 Country share estimation
TABLE 2 Market driver relevance analysis (Current & future impact)
TABLE 3 Market restraint relevance analysis (Current & future impact)
TABLE 4 Latin America point of care diagnostics market estimates, by product, 2013 - 2015 (USD Million)
TABLE 5 Latin America point of care diagnostics market forecasts, by product, 2016 - 2024 (USD Million)
TABLE 6 Latin America point of care infectious diseases diagnostics market estimates, by disease, 2013 - 2015 (USD Million)
TABLE 7 Latin America point of care infectious diseases diagnostics market forecasts, by disease, 2016 - 2024 (USD Million)
TABLE 8 Latin America point of care diagnostics market estimates, by end-use, 2013 - 2015 (USD Million)
TABLE 9 Latin America point of care diagnostics market forecasts, by end-use, 2016 - 2024 (USD Million)
TABLE 10 Brazil point of care diagnostics market estimates, by product, 2013 - 2015 (USD Million)
表11巴西的护理诊断市场forecasts, by product, 2016 - 2024 (USD Million)
TABLE 12 Brazil point of care infectious diseases diagnostics market estimates, by disease, 2013 - 2015 (USD Million)
TABLE 13 Brazil point of care infectious diseases diagnostics market forecasts, by disease, 2016 - 2024 (USD Million)
TABLE 14 Brazil point of care diagnostics market estimates, by end-use, 2013 - 2015 (USD Million)
TABLE 15 Brazil point of care diagnostics market forecasts, by end-use, 2016 - 2024 (USD Million)
TABLE 16 Mexico point of care diagnostics market estimates, by product, 2013 - 2015 (USD Million)
TABLE 17 Mexico point of care diagnostics market forecasts, by product, 2016 - 2024 (USD Million)
TABLE 18 Mexico point of care infectious diseases diagnostics market estimates, by disease, 2013 - 2015 (USD Million)
TABLE 19 Mexico point of care infectious diseases diagnostics market forecasts, by disease, 2016 - 2024 (USD Million)
TABLE 20 Mexico point of care diagnostics market estimates, by end-use, 2013 - 2015 (USD Million)
TABLE 21 Mexico point of care diagnostics market forecasts, by end-use, 2016 - 2024 (USD Million)
TABLE 22 Chile point of care diagnostics market estimates, by product, 2013 - 2015 (USD Million)
TABLE 23 Chile point of care diagnostics market forecasts, by product, 2016 - 2024 (USD Million)
TABLE 24 Chile point of care infectious diseases diagnostics market estimates, by disease, 2013 - 2015 (USD Million)
TABLE 25 Chile point of care infectious diseases diagnostics market forecasts, by disease, 2016 - 2024 (USD Million)
TABLE 26 Chile point of care diagnostics market estimates, by end-use, 2013 - 2015 (USD Million)
TABLE 27 Chile point of care diagnostics market forecasts, by end-use, 2016 - 2024 (USD Million)
TABLE 28 Argentina point of care diagnostics market estimates, by product, 2013 - 2015 (USD Million)
TABLE 29 Argentina point of care diagnostics market forecasts, by product, 2016 - 2024 (USD Million)
TABLE 30 Argentina point of care infectious diseases diagnostics market estimates, by disease, 2013 - 2015 (USD Million)
表31日阿根廷的传染性疾病es diagnostics market forecasts, by disease, 2016 - 2024 (USD Million)
TABLE 32 Argentina point of care diagnostics market estimates, by end-use, 2013 - 2015 (USD Million)
TABLE 33 Argentina point of care diagnostics market forecasts, by end-use, 2016 - 2024 (USD Million)

List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Penetration & growth prospect mapping
FIG. 5 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 6 Porter’s Five Forces Analysis
FIG. 7 Latin America POC diagnostics market product outlook key takeaways
FIG. 8 Latin America POC diagnostics market: product movement analysis
FIG. 9 Latin America POC glucose testing market, 2013 - 2024 (USD Million)
FIG. 10 Latin America POC Hb1Ac market, 2013 - 2024 (USD Million)
FIG. 11 Latin America POC coagulation diagnostics market, 2013 - 2024 (USD Million)
FIG. 12 Latin America POC fertility diagnostics market, 2013 - 2024 (USD Million)
FIG. 13 Latin America POC cardiac markers market, 2013 - 2024 (USD Million)
FIG. 14 Latin America POC infectious disease testing market, 2013 - 2024 (USD Million)
FIG. 15 Latin America HIV POC market, 2013 - 2024 (USD Million)
FIG. 16 Latin America Clostridium difficile POC market, 2013 - 2024 (USD Million)
FIG. 17 Latin America HBV POC market, 2013 - 2024 (USD Million)
FIG. 18 Latin America Pneumonia or Streptococcus associated infections market, 2013 - 2024 (USD Million)
FIG. 19 Latin America Respiratory syncytial virus (RSV) POC market, 2013 - 2024 (USD Million)
FIG. 20 Latin America HPV POC market, 2013 - 2024 (USD Million)
FIG. 21 Latin America Influenza/Flu POC market, 2013 - 2024 (USD Million)
FIG. 22 Latin America HCV POC market, 2013 - 2024 (USD Million)
FIG. 23 Latin America MRSA POC market, 2013 - 2024 (USD Million)
FIG. 24 Latin America TB and drug-resistant TB POC market, 2013 - 2024 (USD Million)
FIG. 25 Latin America HSV POC market, 2013 - 2024 (USD Million)
FIG. 26 Latin America Other Infectious Diseases market, 2013 - 2024 (USD Million)
FIG. 27 Latin America POC primary care systems market, 2013 - 2024 (USD Million)
FIG. 28 Latin America POC hematology market, 2013 - 2024 (USD Million)
FIG. 29 Latin America POC decentralized clinical chemistry diagnostics market, 2013 - 2024 (USD Million)
FIG. 30 Latin America POC feces testing market, 2013 - 2024 (USD Million)
FIG. 31 Latin America POC blood gas and electrolytes analyzers market, 2013 - 2024 (USD Million)
FIG. 32 Latin America POC ambulatory chemistry market, 2013 - 2024 (USD Million)
FIG. 33 Latin America POC urinalysis market, 2013 - 2024 (USD Million)
FIG. 34 Latin America POC drug abuse testing market, 2013 - 2024 (USD Million)
FIG. 35 Latin America POC diagnostics market end-use outlook key takeaways
图36拉丁美洲POC诊断market:end-use movement analysis
FIG. 37 Latin America Clinic based POC diagnostics market, 2013 - 2024 (USD Million)
FIG. 38 Latin America Hospital-based POC diagnostics market, 2013 - 2024 (USD Million)
FIG. 39 Latin America Home healthcare based POC diagnostics market, 2013 - 2024 (USD Million)
FIG. 40 Latin America Assisted living healthcare facilities based POC diagnostics market, 2013 - 2024 (USD million)
FIG. 41 Latin America Laboratories based POC diagnostics market, 2013 - 2024 (USD Million)
FIG. 42 Latin America Other healthcare establishments based POC diagnostics market, 2013 - 2024 (USD Million)
FIG. 43 Regional market place: Key takeaways
FIG. 44 Regional outlook, 2015 & 2024
FIG. 45 Latin America. point of care diagnostics market, 2013 - 2024 (USD Million)
FIG. 46 Brazil point of care diagnostics market, 2013 - 2024 (USD Million)
图47墨西哥的护理诊断市场,2013 - 2024 (USD Million)
FIG. 48 Chile point of care diagnostics market, 2013 - 2024 (USD Million)
FIG. 49 Argentina point of care diagnostics market, 2013 - 2024 (USD Million)
FIG. 50 Strategy framework
FIG. 51 Participant categorization